-
LEMS Patients’ Cancer Risk Is Assessable With Newly Validated Tool
A new tool for estimating a LEMS patient’s risk of developing small cell lung cancer has been validated by scientists in a new study. Click here to read more about it.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.